- Home
- ATHA vs CNEY Comparison
ATHA vs CNEY Comparison
Compare ATHA & CNEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- CNEY
- Stock Information
- Founded
- ATHA 2011
- CNEY 2018
- Country
- ATHA United States
- CNEY China
- Employees
- ATHA N/A
- CNEY N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- CNEY Major Chemicals
- Sector
- ATHA Health Care
- CNEY Industrials
- Exchange
- ATHA Nasdaq
- CNEY Nasdaq
- Market Cap
- ATHA 14.8M
- CNEY 12.9M
- IPO Year
- ATHA 2020
- CNEY 2021
- Fundamental
- Price
- ATHA $3.82
- CNEY $2.11
- Analyst Decision
- ATHA
- CNEY
- Analyst Count
- ATHA 0
- CNEY 0
- Target Price
- ATHA N/A
- CNEY N/A
- AVG Volume (30 Days)
- ATHA 48.3K
- CNEY 37.7K
- Earning Date
- ATHA 11-06-2025
- CNEY 01-01-0001
- Dividend Yield
- ATHA N/A
- CNEY N/A
- EPS Growth
- ATHA N/A
- CNEY N/A
- EPS
- ATHA N/A
- CNEY N/A
- Revenue
- ATHA N/A
- CNEY $36,049,275.00
- Revenue This Year
- ATHA N/A
- CNEY N/A
- Revenue Next Year
- ATHA N/A
- CNEY N/A
- P/E Ratio
- ATHA N/A
- CNEY N/A
- Revenue Growth
- ATHA N/A
- CNEY N/A
- 52 Week Low
- ATHA $2.20
- CNEY $1.56
- 52 Week High
- ATHA $8.26
- CNEY $21.61
- Technical
- Relative Strength Index (RSI)
- ATHA 63.70
- CNEY 41.89
- Support Level
- ATHA $3.61
- CNEY $2.08
- Resistance Level
- ATHA $4.04
- CNEY $2.36
- Average True Range (ATR)
- ATHA 0.25
- CNEY 0.15
- MACD
- ATHA -0.16
- CNEY -0.03
- Stochastic Oscillator
- ATHA 20.92
- CNEY 4.00
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
About CNEY CN Energy Group Inc.
CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.